| Novel Transdermal Ketoprofen Gel Formulation for Knee Osteoarthritis (NCT07319728) | New Valley University | 2025-05-10 |
| Imatinib and Trametinib for KRAS-mutated Solid Tumor (NCT06962254) | China Medical University Hospital | 2025-05-10 |
| Safety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or More (NCT06954818) | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2025-05-10 |
| NW-301 TCR-T in Patients With Advanced Solid Tumor (NCT06956261) | Peking University | 2025-05-10 |
| Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers (NCT06963411) | Kokua Pharma Inc. | 2025-05-09 |
| ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74 (NCT06714513) | Quratis Inc. | 2025-05-09 |
| A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects (NCT06921590) | Alzamend Neuro, Inc. | 2025-05-09 |
| Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors (NCT06927297) | West China Hospital | 2025-05-09 |
| Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer (NCT06972576) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-05-09 |
| A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients (NCT06911827) | Qilu Pharmaceutical Co., Ltd. | 2025-05-09 |
| Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy (NCT06851767) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-05-09 |
| Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir (NCT07007806) | Atea Pharmaceuticals, Inc. | 2025-05-09 |
| Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults (NCT06821126) | ANRS, Emerging Infectious Diseases | 2025-05-09 |
| A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus (NCT06937203) | Arrowhead Pharmaceuticals | 2025-05-09 |
| A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer (NCT07229599) | Minghui Pharmaceutical (Hangzhou) Ltd | 2025-05-09 |
| A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects (NCT06974487) | Gan & Lee Pharmaceuticals. | 2025-05-08 |
| A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants (NCT06973005) | AstraZeneca | 2025-05-08 |
| A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers (NCT06870487) | Pfizer | 2025-05-08 |
| A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902 in Healthy Subjects (NCT06948799) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2025-05-08 |
| Lipomas Treated With Subcutaneous Injections of Cooled or Warmed Sodium Chloride (NCT06820164) | West Virginia University | 2025-05-08 |
| A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia (NCT06853444) | Shanghai Escugen Biotechnology Co., Ltd | 2025-05-08 |
| Clinical Trials of Quadrivalent Influenza Vaccine (NCT06824519) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2025-05-08 |
| Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers (NCT07319559) | Daewon Pharmaceutical Co., Ltd. | 2025-05-08 |
| A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy (NCT06907875) | Epicrispr Biotechnologies, Inc. | 2025-05-08 |
| Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer (NCT06992583) | Chongqing Precision Biotech Co., Ltd | 2025-05-08 |
| Effect of YAP1-inhibition in Surgical Wounds. (NCT06944249) | Jöri Pünchera | 2025-05-08 |
| Clinical Trial of PCV24 in Infants Aged 2-23 Months (NCT06800261) | Sinovac Life Sciences Co., Ltd. | 2025-05-08 |
| A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP) (NCT06944925) | Bambusa Therapeutics | 2025-05-08 |
| Accelerator-based BNCT (Boron Neutron Capture Therapy) for Head and Neck Carcinoma. (NCT07058116) | Neutron Therapeutics, LLC | 2025-05-08 |
| Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy (NCT06450106) | SURGE Therapeutics | 2025-05-08 |
| Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults (NCT06965881) | GRIN Therapeutics, Inc. | 2025-05-08 |
| Exploratory Clinical Study on Memory NK Cell Therapy for Advanced Metastatic Solid Tumors (NCT07274449) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2025-05-08 |
| TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer (NCT06868433) | Emory University | 2025-05-08 |
| A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis (NCT07038720) | Usynova Pharmaceuticals Ltd. | 2025-05-08 |
| SN514-066b Enzyme in Deep Partial Thickness Burns (NCT06628037) | SERDA bv | 2025-05-08 |
| Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors (NCT06840821) | Mainline Biosciences (Shanghai) Co., Ltd | 2025-05-08 |
| Efficacy of Selective COX-2 Inhibitors in Relieving Orthodontic Pain (NCT07559682) | Sharif Medical Research Center | 2025-05-08 |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 Injection (NCT06934408) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2025-05-08 |
| A Study to Assess the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Relative to a Prefilled Syringe in Healthy Adult Participants (NCT06946524) | AbbVie | 2025-05-08 |
| Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure (NCT06996392) | Third Affiliated Hospital, Sun Yat-Sen University | 2025-05-07 |
| A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers (NCT06889012) | Boryung Pharmaceutical Co., Ltd | 2025-05-07 |
| Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib (NCT06997276) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2025-05-07 |
| A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma (NCT06939283) | Werewolf Therapeutics, Inc. | 2025-05-07 |
| HS-10502 Combination Treatment in Patients With Advanced Solid Tumors (NCT06769425) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2025-05-07 |
| Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA (NCT06600698) | Milton S. Hershey Medical Center | 2025-05-07 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors (NCT06959706) | Tagworks Pharmaceuticals BV | 2025-05-07 |
| A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors (NCT06932952) | Byondis B.V. | 2025-05-07 |
| The Study of [14C] GZR18 (NCT07119450) | Gan & Lee Pharmaceuticals. | 2025-05-07 |
| A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants (NCT06869018) | Eli Lilly and Company | 2025-05-07 |
| The Safety and Dosimetry Study of 177Lu-LNC1003 Injection (NCT06237491) | Yantai LNC Biotechnology Singapore PTE. LTD. | 2025-05-07 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer (NCT06799286) | Bristol-Myers Squibb | 2025-05-07 |
| A Study to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for Chronic Hepatitis B Virus Infection, in Healthy Adults (NCT06989788) | AstriVax Therapeutics | 2025-05-06 |
| Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors (NCT07001592) | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 2025-05-06 |
| CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus (NCT06839976) | Children's Hospital of Philadelphia | 2025-05-06 |
| A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders (NCT06680037) | TG Therapeutics, Inc. | 2025-05-06 |
| A Clinical Study of AK139 in Healthy Subjects (NCT06947109) | Akeso | 2025-05-06 |
| A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function (NCT06929156) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-05-06 |
| A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants (NCT06948747) | AstraZeneca | 2025-05-06 |
| Safety of HRX215 in Patients After Minor and Major Liver Resection (NCT06638502) | HepaRegeniX GmbH | 2025-05-06 |
| A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies (NCT06974734) | Pfizer | 2025-05-06 |
| A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours (NCT06868199) | LaNova Medicines Limited | 2025-05-06 |
| Exploring the Utility of [18F]3F4AP for Demyelination Imaging (NCT06999434) | Yale University | 2025-05-05 |
| STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas (NCT06975293) | STORM Therapeutics LTD | 2025-05-05 |
| A Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Carbamazepine on INCB123667 When Administered Orally to Healthy Adult Participants (NCT06909162) | Incyte Corporation | 2025-05-05 |
| A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants (NCT06955741) | Bristol-Myers Squibb | 2025-05-05 |
| NASA Prebreathe Study (NCT06740305) | Duke University | 2025-05-05 |
| Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma (NCT06514898) | University of Florida | 2025-05-05 |
| LH-001 vs Placebo in Healthy Participants (NCT06546449) | Chien-Liang Lin | 2025-05-05 |
| Treatment of Moderate to Severe Refractory Crohn's Disease (NCT06721962) | Tr1X, Inc. | 2025-05-05 |
| A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee (NCT06828666) | Britecyte | 2025-05-05 |
| Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy (NCT06439836) | National Cancer Institute (NCI) | 2025-05-05 |
| A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects (NCT06939504) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-05-04 |
| Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118 (NCT06846710) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2025-05-02 |
| Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) (NCT06810778) | Jonsson Comprehensive Cancer Center | 2025-05-02 |
| Drug-Drug Interaction Study of Casdatifan in Healthy Adult Participants (ARC-29) (NCT06919991) | Arcus Biosciences, Inc. | 2025-05-02 |
| Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis (NCT06934252) | TRex Bio, Inc. | 2025-05-02 |
| A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer (NCT06892548) | BioNTech SE | 2025-05-02 |
| Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC (NCT06934590) | GeneCraft Inc. | 2025-05-01 |
| Treatment of Nosebleeds in the Emergency Department With Powder Tranexamic Acid (NCT06997796) | Dr. Anne Conlin | 2025-05-01 |
| Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients (NCT06852625) | Fundacion Clinic per a la Recerca Biomédica | 2025-05-01 |
| NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC (NCT06966583) | Sichuan University | 2025-05-01 |
| Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer (NCT06916494) | First Affiliated Hospital of Chongqing Medical University | 2025-05-01 |
| A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma (NCT06948994) | Guangzhou Women and Children's Medical Center | 2025-05-01 |
| Project CARE-D - Online Caregiver Education for Dementia (NCT07377318) | Texas Christian University | 2025-05-01 |
| Autologous Bone Marrow Aspirate (IV) and Bone Marrow Concentrate (Intranasal) for Parkinson's Disease and Parkinson-Plus Syndromes (SPARC-PD) (NCT07751640) | Apeiron Research Center | 2025-05-01 |
| The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis (NCT06958939) | Ting Chang, MD | 2025-05-01 |
| Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors (NCT06932094) | Qilu Pharmaceutical Co., Ltd. | 2025-05-01 |
| A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017 (NCT06980207) | Luye Pharma Group Ltd. | 2025-05-01 |
| The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia (NCT06949904) | Mian Muhammad Hassan Ahmed | 2025-05-01 |
| UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases (NCT06978738) | Changzhou No.2 People's Hospital | 2025-05-01 |
| Impact of Chromium Supplementation on Glucido-lipidic Metabolism, Oxidative Stress and Inflammatory State in Patients with Gestational Diabetes (NCT06860087) | University of Kasdi Merbah | 2025-05-01 |
| A Study of QLM2011 in Subjects With Advanced Solid Tumors (NCT06925659) | Qilu Pharmaceutical (Hainan) Co., Ltd. | 2025-05-01 |
| Repeated Neurocognitive Measurements in Depressed Patients (NCT05991232) | Jay Fournier | 2025-05-01 |
| Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients (NCT06761937) | Erasmus Medical Center | 2025-05-01 |
| Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY) (NCT06683755) | M.D. Anderson Cancer Center | 2025-05-01 |
| A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers (NCT04762082) | Seattle Gummy Company | 2025-05-01 |
| Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET (NCT06482307) | University Medical Center Groningen | 2025-05-01 |
| A Single-Arm, Open Phase I Clinical Study of Selinexor in Combination With Azacitidine for the Treatment of High-Risk AML/MDS Patients After Allo-HSCT (NCT07779031) | Liping Dou | 2025-05-01 |
| A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies (NCT03050190) | Shenzhen Geno-Immune Medical Institute | 2025-05-01 |
| Wether VNS in Early Stage (3 Months) is Safe and More Beneficial for Post-stroke Motor Rehabilitation (NCT06938243) | Qilu Hospital of Shandong University | 2025-05-01 |